Massive Bio
PrivateLast Round
Corporate Funding
Jan 15, 2025
Total Funding Raised
$38.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Massive Bio is a health technology company that provides an artificial intelligence-driven platform designed to connect cancer patients to biopharmaceutical clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Healthcare Analytics, Patient Engagement
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Massive Bio Comparables
Compare Massive Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leal Health | 84% | |
| TriNetX | 81% | |
| Paradigm Health | 81% |
Massive Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jan 15, 2025 | ||||
| Series B | Dec 15, 2022 | ||||
| Series B | Jun 3, 2022 | ||||
| Grant | Dec 17, 2020 | ||||
| Series A | Nov 3, 2020 | ||||
Seed | May 2, 2019 |
Key People
Founding team and executive leadership
Massive Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| UL Ventures | Seed |
| International Finance Corporation | Series B |
| KFW DEG | Series B |
| 500 Global | Seed |
| SiteGround Capital | Series B |
| Cavendish Impact Foundation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Ranked #4 on Fast Company's Startup 100 list for Turkey.
- Apr 29, 2026
Broadens access to clinical trials through collaboration.
Recent news
Latest coverage and updates
- expands_offices_inSep 17, 2026
Massive Bio, Inc. expanded offices in Asia on Sep 17th '26.
- expands_offices_toSep 17, 2026
Massive Bio, Inc. expanded offices to South Korea, Eastern Asia, Asia on Sep 17th '26.
- partners_withSep 9, 2026
Massive Bio, Inc. partnered with PrecisCa on Sep 9th '26.
- recognized_asAug 6, 2026
Massive Bio, Inc. recognized as OpenAI Select Partner on Aug 6th '26.
- invests_intoAug 4, 2026
Massive Bio, Inc. invested into Rivvi LLC in investment on Aug 4th '26.
Massive Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Massive Bio's valuation, stock price, and market status.
Is Massive Bio a public or private company?
Massive Bio is a private company.
What is the current stock price of Massive Bio?
Massive Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Massive Bio worth (valuation)?
Valuation information for Massive Bio is not publicly available.
Can I buy Massive Bio stock?
Massive Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Massive Bio's last funding round?
Massive Bio's most recent funding round was Series B on June 2, 2022.
Who are the main investors in Massive Bio?
Key investors in Massive Bio include Revo Capital.
Will Massive Bio IPO soon?
No public IPO plans have been announced for Massive Bio.
How can I track Massive Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Massive Bio's secondary market activity and sign up for updates.